MTOR and cognitive disorder: In connection with cognitive impairment, rapamycin, an mTOR inhibitor, can reverse the increase of mTOR activity in PFC like a 5-HT6 antagonist, thus improving cognitive disorder induced by 5-HT6 agonists [78].